| Holstein, Jens (BioNTech 202107– CFO before MorphoSys 201105–202012 CFO before Fresenius Kabi) |
Chief Financial Officer (CFO) |
BioNTech (Group) |
Mainz |
| Huiskamp, Chris (Isarna Therapeutics 202109 CFO) |
Chief Financial Officer (CFO) |
Isarna Therapeutics GmbH |
München (Munich) |
| Irsfeld, Marcus (iOmx Therapeutics 201910– CFO before ProCorde GmbH + Averitas Pharma Inc) |
Chief Financial Officer (CFO) |
iOmx Therapeutics AG |
Martinsried |
| Kaeser, Joe (Siemens 200806 CFO) |
Chief Financial Officer (CFO) |
Siemens (Group) |
München (Munich) |
| Kirjner, Carlos (Celonis 202106– CFO before Google + Sanford C Bernstein + McKinsey & Co) |
Chief Financial Officer (CFO) |
Celonis (Group) |
München (Munich) |
| Kosijer, Dusan (Apceth 201705– CFO of Apceth Biopharma GmbH joined 10/16 before Accovion GmbH) |
Chief Financial Officer (CFO) |
Resonac (Group) |
München (Munich) |
| Kraus, Harald (Bio-Gate AG 200603 CFO) |
Chief Financial Officer (CFO) |
Bio-Gate (Group) |
Nürnberg (Nuremberg) |
| Lee, Sung (MorphoSys 202102–202303 CFO before Sangamo + Gilead Sciences LEFT 3/23) |
Chief Financial Officer (CFO) |
MorphoSys (Group) |
Martinsried |
| Leppert, Angelika (Kupando 202209 CFO before Bavaria (govt) 202004 Start-up Coach, Strategy + Corporate Finance) |
Chief Financial Officer (CFO) |
Kupando GmbH |
Brandenburg_o |
| Loeser, Thomas (Tom) (T-Curx 202212– CFO + Viopas Venture Consulting 202211– Managing Partner) |
Chief Financial Officer (CFO) |
T-Curx GmbH |
Würzburg |
| Maleck, Klaus (ITM 202309 CFO before TETEC AG + Evotec + BioGeneriX) |
Chief Financial Officer (CFO) |
ITM (Group) |
Garching |
| Malkomes, Axel-Sven (Medigene 201904 – CFO + Chief BusDev Officer before Barclays + Société Générale + 3i + Merck KGaA) |
Chief Financial Officer (CFO) |
Medigene (Group) |
Martinsried |
| Platte, Ulrich (eTheRNA Immunotherapies 202110 CFO formerly sinYmed UG 201510– Managing Director) |
Chief Financial Officer (CFO) |
eTheRNA (Group) |
Belgium_oo |
| Reinecker, Marcus (Neopharm 201308– CFO at Neovii Biotech GmbH) |
Chief Financial Officer (CFO) |
Neopharm (IL) (Group) |
Gräfelfing |
| Schaffer, Thomas (Biofrontera 201306– CFO before Siemens et al) |
Chief Financial Officer (CFO) |
Biofrontera (Group) |
Leverkusen |
| Schwan, Heinz (Bind-X 202308 CFO) |
Chief Financial Officer (CFO) |
Bind-X (Group) |
Martinsried |
| Seibert, Daniel (Life Technologies 201105 CFO of Geneart AG LEFT Geneart BEFORE 7/12) |
Chief Financial Officer (CFO) |
Thermo Fisher (Group) |
Regensburg |
| Spillner, Enno (Formycon 202304– CFO before Evotec + 4SC + BioM Venture Capital GmbH) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Martinsried |
| Thomas, Ralf P. (Siemens 201711 CFO) |
Chief Financial Officer (CFO) |
Siemens (Group) |
München (Munich) |
| Wagner, Christina (Temedica 202110– CFO before coliquio + OmniaMed Holding + Ventac Partners + Inveni Capital + MWG) |
Chief Financial Officer (CFO) |
Temedica GmbH |
München (Munich) |
| Beier, Wolfgang (Leon-Nanodrugs 201010– Medical Director + Co-Founder) |
Chief Medical Officer (CMO) |
H.A.C. Pharma (FR) |
München (Munich) |
| Danhauser-Riedl, Susanne (4SC 201401– CMO before GSK GmbH + MedacSchering Onkologie GmbH) |
Chief Medical Officer (CMO) |
4SC (Group) |
Martinsried |
| Fagerberg, Jan (Enterome 202103 CMO formerly Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Enterome S.A. |
Paris |
| Fricke, Harald (Apogenix GmbH 200511– CMO + COO before Fresenius Biotech + Baxter + GSK) |
Chief Medical Officer (CMO) |
Apogenix AG |
Heidelberg |
| Friedrich, Benjamin (Temedica 202201 CMO) |
Chief Medical Officer (CMO) |
Temedica GmbH |
München (Munich) |
| George, Martine (GPC Biotech 200604– Senior VP + CMO) |
Chief Medical Officer (CMO) |
HOPP Group (family of Dietmar Hopp) |
Martinsried |
| Heeger, Steffen (Selvita 201802– CMO before MorphoSys 201312– Head of Clinical Research before Merck Serono) |
Chief Medical Officer (CMO) |
Selvita (Group) |
Kraków |
| Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) |
Chief Medical Officer (CMO) |
Zambon (Group) |
München (Munich) |
| Hermann, Frank (Thermosome 202312– CMO before Catalym + BioNTech + 4SC + BMS) |
Chief Medical Officer (CMO) |
Thermosome GmbH |
Martinsried |
| Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
Chief Medical Officer (CMO) |
Affectis Pharmaceuticals AG |
Dortmund |
| Mühler, Andreas (Immunic 201604– CMO + Co-Founder) |
Chief Medical Officer (CMO) |
Immunic (Group) |
Gräfelfing |
| Pagel, Philipp (Numares 201707 CMO) |
Chief Medical Officer (CMO) |
Numares (Group) |
Regensburg |
| Pinkernell, Kai (Medigene 201602– CMO before Miltenyi Biotec + Cytori Therapeutics) |
Chief Medical Officer (CMO) |
Medigene (Group) |
Martinsried |
| Reinhardt, Carsten (Immatics 200910– CMO before Micromet 200506– CMO before Roche) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Tübingen |
| Valor, Santiago (Synlab 201603 CMO) |
Chief Medical Officer (CMO) |
Synlab (Group) |
Augsburg |
| Yule, Murray (iOmx Therapeutics 202202– CMO before MorphoSys) |
Chief Medical Officer (CMO) |
iOmx Therapeutics AG |
Martinsried |
| Binder, Klaus (Coral BioNet 201107 COO of Scil Technology GmbH) |
Chief Operating Officer (COO) |
Coral BioNet (Group) |
Martinsried |
| Grau, Ulrich (Micromet 201106–2012 COO before Lux Biosciences CEO before Enzon 2002–2005 CSO before BASF/Knoll) |
Chief Operating Officer (COO) |
Amgen (Group) |
München (Munich) |
| Jung, Marion (T-Curx 202402– COO before ChromoTek Managing Director + Co-Founder + Earlybird Ventures) |
Chief Operating Officer (COO) |
T-Curx GmbH |
Würzburg |
| Kaletta, Titus (Numares 201607– Executive Board Member COO before Consulting + Galantos Pharma + Devgen) |
Chief Operating Officer (COO) |
Numares (Group) |
Regensburg |
| Kick, Benjamin (Plectonic Biotech 202211 COO + Co-Founder) |
Chief Operating Officer (COO) |
Plectonic Biotech GmbH |
Garching |
| Lemus, Dave (Proteros 201712– COO + CFO before Medigene + Sigma-Tau Pharmaceuticals + MorphoSys) |
Chief Operating Officer (COO) |
Proteros (Group) |
Martinsried |
| Lensky, Stephan (EpimAb Biotherapeutics 201610 COO/CBO) |
Chief Operating Officer (COO) |
EpimAb Biotherapeutics (Group) |
Shanghai |
| Moosbauer, Julia (Deepc 202303 COO + Co-Founder) |
Chief Operating Officer (COO) |
Deepc GmbH |
München (Munich) |
| Neeleman, Christiaan (Definiens 201309– COO before among others Philips Healthcare) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
München (Munich) |
| Pelster, Dirk (Trion Pharma 201106 COO) |
Chief Operating Officer (COO) |
Trion Pharma GmbH |
München (Munich) |
| Pötting, Sierk (BioNTech 202107– COO joined 201409 as CFO before Sandoz Inc/Novartis + McKinsey) |
Chief Operating Officer (COO) |
BioNTech (Group) |
Mainz |
| Schunk, Markus (AstraZeneca 201809– COO at Definiens before CEO at Holtzbrinck Digital joined Holtzbrinck 2004 + KPMG) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
München (Munich) |
| Strasser, Ralf (Dynamic Biosensors 202209 COO + Co-Founder) |
Chief Operating Officer (COO) |
Dynamic Biosensors (Group) |
Martinsried |
| Stubbers, Ron (InGeneron 201710 Head of Operations) |
Chief Operating Officer (COO) |
InGeneron (Group) |
München (Munich) |
| Wallasch, Christian (Atriva Therapeutics 201901 COO before Axxima + U3 + Intercell/Valneva) |
Chief Operating Officer (COO) |
Atriva Therapeutics GmbH |
Martinsried |
| Walter, Monika (Hyglos 2010 Manager Operations) |
Chief Operating Officer (COO) |
Mérieux (Group) |
Bernried |
| Baumgartner, Roland (4SC 201610– promoted CSO joined 2002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Martinsried |
| Deml, Ludwig (Lophius Biosciences 201011 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mikrogen GmbH |
Regensburg |
| Demuth, Tim (MorphoSys 202210– promoted to Chief RnD Officer joined 2017 before Pieris + Merck KGaA + Sandoz) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Martinsried |
| Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Versant Ventures |
Basel BS |
| Funke, Jonas (Plectonic Biotech 202211 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Plectonic Biotech GmbH |
Garching |
| Godl, Klaus (Kinaxo 200910 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Martinsried |
| Hentsch, Bernd (4SC 201009–201403 Chief Development Officer LEFT 3/14) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Martinsried |
| Hinterding, Klaus (Proteros 201202– CSO before Roche + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteros (Group) |
Martinsried |
| Höfer, Constance (Priaxon 201401– Chief Development Officer before Medigene + Merck KGaA + Solvay) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Priaxon AG |
München (Munich) |
| Jakob, Uwe (Suppremol 200808 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Baxter (Group) |
Martinsried |
| Kohlhof, Hella (Immunic 201701– CSO before 4SC before Univ Munich) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Immunic (Group) |
Gräfelfing |
| Müller, Gerhard (Gotham Therapeutics 201708– CSO before Mercachem BV + Proteros Fragments + Axxima + Organon + Bayer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Gotham Therapeutics (Group) |
Martinsried |
| Pahl, Andreas (Wilex 201606– Head of RnD before CSO at Heidelberg Pharma) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Heidelberg Pharma (Group) |
München (Munich) |
| Peters, Malte (MorphoSys 201703–202212 Chief Development Officer before Sandoz + Novartis + Micromet RETIRED 12/22) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Martinsried |
| Schendel, Dolores J. (Medigene 202207– CSO + Head of RnD before CEO + CMO + Triant + HelmholtzZentrum München) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Medigene (Group) |
Martinsried |
| Scholz, Martin (Leukocare AG 201105 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Leukocare (Group) |
Martinsried |
| Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
Babraham, Cambridgeshire |
| Seidl, Andreas (Formycon 202207– CSO beforeLeukocare + Novartis + Sandoz Biopharmaceuticals + Hexal) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Formycon (Group) |
Martinsried |
| Sproll, Marlies (MorphoSys 201711– Special Adviser to CEO before 200510–201710 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Martinsried |
| Stauder, Gerhard (Antisense Pharma 200204 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Isarna Therapeutics GmbH |
Regensburg |
| Tetko, Igor (eADMET GmbH 201109 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
eADMET GmbH |
Neuherberg |
| Ullmann, Dirk (Evotec 202209 Global Head Drug Discovery Services before Proteros Biostructures + Evotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Hamburg |
| Vornlocher, Hans-Peter (Roche Kulmbach 200809 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
LGC (Group) |
Kulmbach |
| Weinberger, Klaus (Bavarian Nordic 201202 VP R&D at Bavarian Nordic GmbH before Biocrates CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bavarian Nordic (Group) |
Martinsried |
| Almasi, Barna (Imaging Service AG 200906 CTO) |
Chief Technology/Technical Officer (CTO) |
Imaging Service AG |
Niederpöcking |
| Binnig, Gerd (Definiens 201210 CTO + Co-founder + Nobel Laureate) |
Chief Technology/Technical Officer (CTO) |
AstraZeneca (Group) |
München (Munich) |
| Sykora, Lorenz (Irubis 202005 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Irubis GmbH |
München (Munich) |
| Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) |
Chief Technology/Technical Officer (CTO) |
Resonac (Group) |
München (Munich) |
| Wagener, Michael (Bio-Gate AG 201104 CTO) |
Chief Technology/Technical Officer (CTO) |
Bio-Gate (Group) |
Nürnberg (Nuremberg) |
| Wittmeier, Sebastian (Curefab GmbH 2008– CTO + Co-founder) |
Chief Technology/Technical Officer (CTO) |
Curefab GmbH |
München (Munich) |
| Langer, Ludger (MorphoSys 201312– Head of Clinical Operations + Project Management before PRA International) |
Clinical Research Manager |
MorphoSys (Group) |
Martinsried |
| Burgstaller, Petra (BioM 202001 Senior Manager Start-ups + Funding) |
Cluster Manager |
Bavaria (govt region) |
Martinsried |
| Domdey, Horst (BioM 1997–202212 Managing Director RETIRED 12/22) |
Cluster Manager |
Bavaria (govt region) |
Martinsried |
| Huss, Ralf (Bavaria (govt) 202301– Managing Director of BioM before Augsburg Univ Hospital + Definiens + Apceth + Roche) |
Cluster Manager |
Bavaria (govt region) |
Martinsried |
| Clark, Martin (MorphoSys 201205– head Central Purchasing + Logistics before Sandoz Biopharmaceuticals + Basilea) |
Commercial Manager_oo |
MorphoSys (Group) |
Martinsried |
| Angermayer, Christian (Apeiron Investment 202010 Founder formerly Co-founder of Ribopharma) |
Company Founder |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta_oo |
| Bergmann, Thorald (Bergmann Messgeräte 1991– founder) |
Company Founder |
Bergmann Messgeräte Entwicklungs KG (BME) |
Murnau a. Staffelsee |
| Gasteiger, Johann (Univ Erlangen-Nuremberg 1994–) |
Company Founder |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Nürnberg (Nuremberg) |
| Heinrich, Günther (Epidauros Founder) |
Company Founder |
Danaher (Group) |
Bernried |
| Holsboer, Florian (MPI of Psychiatry + Neuronova Pharmaceuticals AG founder) |
Company Founder |
Max Planck Society for the Advancement of Science |
München (Munich) |
| Moarefi, Ismail (Crelux 200502– co-founder) |
Company Founder |
WuXi PharmaTech (Group) |
Martinsried |
| Strüngmann, Andreas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Strüngmann, Thomas (Hexal founder + Biotech investor) |
Company Founder |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Ungerer, Martin (Corimmun 2006 Co-founder before Procorde) |
Company Founder |
Johnson & Johnson (JnJ) (Group) |
Martinsried |
| Zaimenko, Inna (Versatile Biology Lab 202210 Founder) |
Company Founder |
Versatile Biology Lab (Inna Zaimenko) |
München (Munich) |
| Emmerich, Wolf-Dieter (Netzsch Instruments) |
Consultant (economic/technology) |
Netzsch (Group) |
Bayern_o |
| Kaltenbach, Thilo (Roland Berger 202307 Partner) |
Consultant (economic/technology) |
Roland Berger & Partner (München) |
München (Munich) |
| Klingan, Franz-Robert (Bain & Co 201610 Partner) |
Consultant (economic/technology) |
Bain & Company |
|
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
